Palvella Therapeutics PVLA Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Palvella Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's book value per share?
- Palvella Therapeutics (PVLA) reported book value per share of $17.75 in Q1 2026.
- How has Palvella Therapeutics's book value per share changed year-over-year?
- Palvella Therapeutics's book value per share increased by 251.8% year-over-year, from $5.05 to $17.75.
- What is the long-term trend for Palvella Therapeutics's book value per share?
- Over 3 years (2020 to 2025), Palvella Therapeutics's book value per share has grown at a 63.5% compound annual growth rate (CAGR), from $0.57 to $2.49.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.